# Efficacy and Safety of Sotalol in Children With Arrhythmia

Study · id `cardio:ct-nct03895411` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03895411](<https://clinicaltrials.gov/study/NCT03895411>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03895411

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 500 participants.

## Technical summary

Registry record NCT03895411. Randomized; quadruple masking; primary purpose treatment. Start 2019-08 (anticipated); primary completion 2020-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 500 participants (planned count; ClinicalTrials.gov record NCT03895411, source copy `cardio:ctgov-nct03895411-2019-03-29`, retrieved 2026-10-26)
- Planned start: 2019-08 (anticipated) (ClinicalTrials.gov record NCT03895411, source copy `cardio:ctgov-nct03895411-2019-03-29`, retrieved 2026-10-26)
- Primary completion: 2020-12 (anticipated) (ClinicalTrials.gov record NCT03895411, source copy `cardio:ctgov-nct03895411-2019-03-29`, retrieved 2026-10-26)
- Completion: 2022-12 (anticipated) (ClinicalTrials.gov record NCT03895411, source copy `cardio:ctgov-nct03895411-2019-03-29`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT03895411, source copy `cardio:ctgov-nct03895411-2019-03-29`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03895411-2019-03-29`, retrieved 2026-10-26)

## The registry's words

- Brief title: Efficacy and Safety of Sotalol in Children With Arrhythmia
- Condition: Arrhythmia
- Intervention (Drug): sotalol
- Intervention (Drug): Propafenone
- Intervention (Drug): betaloc
- Lead sponsor: Shengjing Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry lists this organization as the lead sponsor: Shengjing Hospital (`cardio:org-shengjing-hospital`)

## Provenance

Content hash: a15f16ae6812cf3e6e312f1e6714aa10e7449d11a0ed03e7a7fa6cdf1a5d7a1a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
